REQUEST A DEMO
Total
USD $0.00
Search more companies

Teva Pharmaceuticals Slovakia s.r.o. (Slovakia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Teva Pharmaceuticals Slovakia s.r.o. Profile Updated: March 23, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Teva Pharmaceuticals Slovakia s.r.o. is an enterprise based in Slovakia. Its main office is in Bratislava. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The company was established on February 26, 2005. There are currently 50 - 99 (2023) people employed by Teva Pharmaceuticals Slovakia s.r.o.. The latest financial highlights indicate a net sales revenue increase of 1.53% in 2022. Its’ total assets recorded a growth of 16.64%. In 2022, Teva Pharmaceuticals Slovakia s.r.o.’s net profit margin decreased by 0.3%.

Headquarters
Teslova 26
Bratislava; Bratislavsky; Postal Code: 82102

Contact Details: Purchase the Teva Pharmaceuticals Slovakia s.r.o. report to view the information.

Website: http://www.teva.sk/

Basic Information
Total Employees:
Purchase the Teva Pharmaceuticals Slovakia s.r.o. report to view the information.
Outstanding Shares:
Purchase the Teva Pharmaceuticals Slovakia s.r.o. report to view the information.
Registered Capital:
Purchase the Teva Pharmaceuticals Slovakia s.r.o. report to view the information.
Incorporation Date:
February 26, 2005
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
99.7%
Purchase this report to view the information.
0.3%
Company Performance
Financial values in the chart are available after Teva Pharmaceuticals Slovakia s.r.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
1.53%
Total operating revenue
1.53%
Operating profit (EBIT)
-12.79%
EBITDA
-13.97%
Net Profit (Loss) for the Period
-20.59%
Total assets
16.64%
Total equity
5.81%
Operating Profit Margin (ROS)
-0.32%
Net Profit Margin
-0.3%
Return on Equity (ROE)
-1.82%
Debt to Equity Ratio
0.03%
Quick Ratio
-0.03%
Cash Ratio
-0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?